Ameriprise
MR

Ameriprise’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Ameriprise’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-212,664
Closed -$5.77M – 3978
2015
Q4 		$5.77M Buy
212,664
+766
+0.4% +$19.7K ﹤0.01% 1908
2015
Q3 		$4.63M Buy
211,898
+4,497
+2% +$115K ﹤0.01% 2066
2015
Q2 		$5.91M Sell
207,401
-3,135
-1% -$91.4K ﹤0.01% 2029
2015
Q1 		$5.76M Buy
210,536
+14,648
+7% +$403K ﹤0.01% 2008
2014
Q4 		$5.17M Sell
195,888
-57,641
-23% -$1.69M ﹤0.01% 2026
2014
Q3 		$7.65M Sell
253,529
-38,017
-13% -$1.18M ﹤0.01% 1694
2014
Q2 		$9.18M Buy
291,546
+48
+0% +$1.52K 0.01% 1608
2014
Q1 		$9.43M Buy
291,498
+9,882
+4% +$346K 0.01% 1570
2013
Q4 		$10.2M Buy
281,616
+34,259
+14% +$1.33M 0.01% 1477
2013
Q3 		$9.62M Buy
247,357
+5,554
+2% +$224K 0.01% 1492
2013
Q2 		$9.06M Buy
+241,803
New +$9.55M 0.01% 1494

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ameriprise's MR Position: Q1 2016 in Review

Ameriprise sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 212,664 shares — an estimated $5.77M sold.

Ameriprise first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $10.2M in Q4 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Ameriprise reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Ameriprise sold 212,664 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $5.77M.
  • Ameriprise first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Ameriprise's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $10.2M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Ameriprise's 13F filing for Q1 2016, filed 12 May 2016.